APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 13 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $122,006 | -20.8% | 79,000 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $154,000 | +30.5% | 79,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $118,000 | -6.3% | 79,000 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $126,000 | -99.4% | 79,000 | -99.4% | 0.00% | -99.4% |
| Q4 2021 | $19,501,000 | -0.7% | 12,865,000 | -18.9% | 0.16% | -12.4% |
| Q3 2021 | $19,641,000 | -46.5% | 15,855,000 | -20.1% | 0.18% | -46.4% |
| Q2 2021 | $36,702,000 | +35.4% | 19,851,000 | +3.1% | 0.34% | +74.2% |
| Q1 2021 | $27,103,000 | -14.8% | 19,260,000 | +2.0% | 0.20% | -9.6% |
| Q4 2020 | $31,802,000 | +102.7% | 18,878,000 | +29.2% | 0.22% | +104.7% |
| Q3 2020 | $15,692,000 | – | 14,614,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
| LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
| Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 504,000 | $623,398 | 0.00% |